SERG Technologies is developing a connected platform which enables remote, patient-specific assessment of all Parkinson’s disease motor symptoms, delivering actionable insights that optimise treatment, promote lifestyle changes thus increasing patient mobility and independence.
NK:IO is an Imperial spinout developing small molecule and cell-mediated immunotherapy for the treatment ofcancer. The company is developing techniques aimed at increasing the potential of natural killer cells for use inimmunotherapies for cancer. The company is validating its proof of concept studies after many years of work onnatural killer cell biology. It has progressed
52 North is developing the world’s first finger-prick blood test to provide both a white blood cell count and blood lactate level, enabling rapid triage of chemotherapy patients at risk of life-threatening infections. 52 North is a spin-out from the University of Cambridge.
BKwai is developing machine learning based solutions that enable smarter construction and asset monitoring, by turning big data into engineering intelligence. BKwai spun-out of the University of Cambridge in 2019.
Barocal is developing a zero global warming potential (GWP) alternative to fluid refrigerants, harnessing the barocaloric effect (BCE) in solid refrigerants, where materials undergo large thermal changes on application and removal of pressure to develop cooling and heating systems.
Semarion is a University of Cambridge spin-out from the Cavendish Laboratory. The company is commercialising their SemaCyte® technology, a platform that revolutionises in-vitro cell handling with applications across drug discovery and life sciences R&D.
Diffblue is leading the automation of software creation through the power of AI. Founded by researchers from the University of Oxford, Diffblue Cover uses AI for code to write unit tests that help software teams and organizations efficiently improve their code coverage and quality and to ship software faster, more frequently and with fewer defects.
Wayland Additive Limited (Wayland) has developed a novel electron beam powder bed fusion process for metal additive manufacturing, which removes some of the technical issues which make the process less efficient and flexible than rival technologies and increases the range of metal alloys which can be processed.
Pathfinder Medical is an Imperial spinout MedTech business that has a unique technology to allow surgeons to make connections across blood vessels. There are several applications for this technique, with a key one being for patients with kidney failure who are undergoing dialysis treatment.
Bumblebee Power Limited (Bumblebee) is developing next generation inductive power transfer technology for the wireless recharging of a wide variety of battery-powered devices and vehicles. Bumblebee’s lightweight solution provides a large area in which to position the vehicle to be charged relative to the charging pad, as well as the capability to charge multiple vehicles
OW Smell Made Digital, a UCL and University of Sussex spin-out previously known as OWidgets, has developed technologies that enable the digitisation and commercial exploitation of the human sense of smell. It is a unique and defensible platform technology that provides a unique capability to design, deliver and evaluate smell sensations and the impact these
Emilie joined Parkwalk from Oxford University Innovation, where she worked both in the Investments Team and leading the Startup Incubator, managing over 80 projects and companies from inception to exit. She moved into technology transfer after 14 years as a research scientist, directing pioneering experiments in systems neuroscience in Oxford, Bordeaux and Hamburg. Emilie holds
Before joining Parkwalk in 2021 Canan worked at Arbuthnot Latham as a compliance manager and prior to that she worked in compliance roles in the banking sector. Canan comes from a legal background and has practiced in law firms before changing to a career in Compliance in 2014.
Karolina has nearly a decade of experience in building life sciences and healthcare companies within the Cambridge Cluster. She played a pivotal role in securing pre-seed and seed investment from a stellar syndicate of investors. In 2018 she co-founded and successfully delivered the first life sciences startup accelerator with a portfolio of 20 early-stage ventures
Parkwalk invests in UK companies that are commercialising research and technology that has spun out from a UK university or research-intensive institution. We believe this distinct asset class has the ability not only to generate attractive investment returns but also positive returns for UK plc, and broader society. The technologies we back have normally been
Zetta Genomics is exploiting unique big data technology for the storage and management of genomic data. Advances in genomics including next generation sequencing are driving changes and innovation in healthcare. Despite the potential, ineffective data management of these complex and large data sets has restricted utility. Zetta has developed a system with the appropriate scale
Carbon Re is a University of Cambridge and UCL spin-out, which has developed AI-powered process optimisation software to enable energy efficiency and emission reduction in process industries. Carbon Re’s proprietary software platform, Delta Zero, uses deep reinforcement learning to enable reductions in energy consumption, cost and carbon emissions.
Cheesecake Energy Limited (CEL) is developing a green energy storage technology known as eTanker that stores electricity in the form of compressed air and heat. eTanker is deployed in a modular, containerised package, making it suitable for a range of terrains and applications in industry including local renewable microgrids, electric vehicle fleet charging and heavy industry.
Bonnet is developing a SaaS platform for chargepoint operators (CPOs) and fleets, and a mobile application for EV users to provide reliable, interoperable, and cheap access to a wide range of chargers for users of EV vehicles, both personal and corporate. There are over 50 different charging networks in the UK with unique payment systems,
Helio is commercialising perovskite materials in light-emitting applications such as display panels, whether LCD, OLED or μLED. Perovskites are of strong interest as they are highly efficient and tuneable emitters of pure light. This enables increased brightness, colour range and power efficiency. Helio is a joint spin-out from Oxford and Cambridge Universities and will initially
